CoChat

HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system

Open access

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

HIV-1 Vpr is a viral accessory protein that activates ATR through the induction of DNA replication stress. ATR activation results in cell cycle arrest in G 2 and induction of apoptosis. In the present study, we investigate the role of the ubiquitin/proteasome system (UPS) in the above activity of Vpr. We report that the general function of the UPS is required for Vpr to induce G 2 checkpoint activation, as incubation of Vpr-expressing cells with proteasome inhibitors abolishes this effect. We further investigated in detail the specific E3 ubiquitin ligase subunits that Vpr manipulates. We found that Vpr binds to the DCAF1 subunit of a cullin 4a/DDB1 E3 ubiquitin ligase. The carboxy-terminal domain Vpr(R80A) mutant, which is able to bind DCAF1, is inactive in checkpoint activation and has dominant-negative character. In contrast, the mutation Q65R, in the leucine-rich domain of Vpr that mediates DCAF1 binding, results in an inactive Vpr devoid of dominant negative behavior. Thus, the interaction of Vpr with DCAF1 is required, but not sufficient, for Vpr to cause G 2 arrest. We propose that Vpr recruits, through its carboxy terminal domain, an unknown cellular factor that is required for G 2 -to-M transition. Recruitment of this factor leads to its ubiquitination and degradation, resulting in failure to enter mitosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1743-422x-4-57

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Role of the ubiquitin proteasome system in Vpr-induced G2 arrest. Incubation with epoxomicin or overexpression of Ub(K48R) block Vpr induced G2 arrest when induced by Vpr, but not when induced by the topoisomerase inhibitor, etoposide.
Figure 1 Role of the ubiquitin proteasome system in Vpr-induced G2 arrest. Incubation with epoxomicin or overexpression of Ub(K48R) block Vpr induced G2 arrest when induced by Vpr, but not when induced by the topoisomerase inhibitor, etoposide.CC BY · PubMed Central
Figure 2 Role of DCAF1 in Vpr-induced G2 arrest. A. Identification of Vpr-interacting proteins by affinity chromatography followed by mass spectrometry; band labeled as "c" was identified as being DCAF1. B. Knockdown of DCAF1 abolishes Vpr function. C. Western blot demonstrates efficient knockdown of DCAF1. NS, non-specific siRNA.
Figure 2 Role of DCAF1 in Vpr-induced G2 arrest. A. Identification of Vpr-interacting proteins by affinity chromatography followed by mass spectrometry; band labeled as "c" was identified as being DCAF1. B. Knockdown of DCAF1 abolishes Vpr function. C. Western blot demonstrates efficient knockdown of DCAF1. NS, non-specific siRNA.CC BY · PubMed Central
Figure 3 Co-immunoprecipitation studies with Vpr, DCAF1 and DDB1. A. Flag-DCAF1 was cotransfected into HeLa cells with either HA-Vpr or HA-Vpr(R80A). Immunoprecipitation was performed with either HA or Flag antibody as indicated. Immunoprecipitates were analyzed by WB for the presence of Flag-DCAF1 or HA-Vpr. B. GFP, HA-Vpr, HA-Vpr(R80A), or HA-Vpr(Q65R) constructs were transfected, and immunoprecipitations with HA antibody were performed. Immunoprecipitates were analyzed by WB with an antibody against endogenous DDB1. C. Knockdown of DCAF1 abolishes the association between Vpr and DDB1; HeLa cells were transected with HA-Vpr, in the presence of non-specific (NS) or DCAF1-specific siRNA. 48 hours later, cell extracts were immunoprecipitated with HA antibody and analyzed by WB for the presence of endogenous DDB1. D. HA-Vpr(Q65R) fails to interact with DCAF1.
Figure 3 Co-immunoprecipitation studies with Vpr, DCAF1 and DDB1. A. Flag-DCAF1 was cotransfected into HeLa cells with either HA-Vpr or HA-Vpr(R80A). Immunoprecipitation was performed with either HA or Flag antibody as indicated. Immunoprecipitates were analyzed by WB for the presence of Flag-DCAF1 or HA-Vpr. B. GFP, HA-Vpr, HA-Vpr(R80A), or HA-Vpr(Q65R) constructs were transfected, and immunoprecipitations with HA antibody were performed. Immunoprecipitates were analyzed by WB with an antibody against endogenous DDB1. C. Knockdown of DCAF1 abolishes the association between Vpr and DDB1; HeLa cells were transected with HA-Vpr, in the presence of non-specific (NS) or DCAF1-specific siRNA. 48 hours later, cell extracts were immunoprecipitated with HA antibody and analyzed by WB for the presence of endogenous DDB1. D. HA-Vpr(Q65R) fails to interact with DCAF1.CC BY · PubMed Central
Figure 4 Vpr(R80A) functions as a dominant-negative molecule. HeLa cells were infected with a constant MOI (MOI = 1) of pHR-VPR vector, and a variable MOI (1, 0.5, 0.25) of pHR-GFP, pHR- Vpr(R80A) or pHR-VPR(Q65R, R80A) as indicated. Cell cycle profiles were evaluated at 48 hours post transduction.
Figure 4 Vpr(R80A) functions as a dominant-negative molecule. HeLa cells were infected with a constant MOI (MOI = 1) of pHR-VPR vector, and a variable MOI (1, 0.5, 0.25) of pHR-GFP, pHR- Vpr(R80A) or pHR-VPR(Q65R, R80A) as indicated. Cell cycle profiles were evaluated at 48 hours post transduction.CC BY · PubMed Central
Figure 5 DDB2 is dispensable for Vpr function. Xeroderma pigmentosum complementation group E fibroblasts or control fibroblasts were infected with pHR-VPR or mock-infected and, 48 hours later, cell cycle profile was analyzed.
Figure 5 DDB2 is dispensable for Vpr function. Xeroderma pigmentosum complementation group E fibroblasts or control fibroblasts were infected with pHR-VPR or mock-infected and, 48 hours later, cell cycle profile was analyzed.CC BY · PubMed Central
Figure 6 Changes in Cdt1 protein level are not associated with Vpr expression. Cells were transduced pHR-VPR or mock-transduced, and at 48 hours post-transduction, lysed and assayed for Cdt1 levels by WB.
Figure 6 Changes in Cdt1 protein level are not associated with Vpr expression. Cells were transduced pHR-VPR or mock-transduced, and at 48 hours post-transduction, lysed and assayed for Cdt1 levels by WB.CC BY · PubMed Central
Figure 7 Proposed model for the interaction of Vpr with an E3 ubiquitin ligase. Question mark denotes putative degradation target.
Figure 7 Proposed model for the interaction of Vpr with an E3 ubiquitin ligase. Question mark denotes putative degradation target.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 152

Metadata

Authors
DeHart, J. L., Zimmerman, E. S., Ardon, O., Monteiro-Filho, C. M., Argañaraz, E. R., & Planelles, V.
Affiliations
  • University of Utah (US)
  • Universidade de Brasília (BR)
Corresponding author
Planelles, Vicente
Venue
Virology Journal
Published
2007-06-08
Volume
4
Issue
1
Pages
57-57
ISSN
1743-422X (ISSN-L)
OpenAlex
W2129784359
Cited by
152
References
34
Citations by year
2026: 1 · 2024: 6 · 2023: 4 · 2022: 3 · 2021: 8 · 2020: 4 · 2019: 6 · 2018: 7 · 2017: 5 · 2016: 10 · 2015: 6 · 2014: 17 · 2013: 8 · 2012: 10
FWCI
5.69
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Virology Journal (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Saint Louis University
  • York University
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • National Institutes of Health
  • National Institute of General Medical Sciences (T32 GM 07464, T32GM007464)
  • National Institute of Allergy and Infectious Diseases (R56AI049057, AI 49057, R01AI049057, T32AI055434)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
HIV-1 Vpr, G2 checkpoint, ubiquitin-proteasome system, replication stress, DCAF1, proteasome inhibitors, leucine-rich domain, apoptosis, viral accessory proteins
MeSH terms
Cell Line, HeLa Cells, Humans, Kidney, Oligopeptides, RNA, Viral, Transfection, Virus Replication, HIV-1, G2 Phase, Gene Products, vpr, Ubiquitin, RNA, Small Interfering, Proteasome Endopeptidase Complex, vpr Gene Products, Human Immunodeficiency Virus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system. https://app.cochat.ai/papers/10.1186/1743-422x-4-57
The paper
DeHart, J. L., Zimmerman, E. S., Ardon, O., Monteiro-Filho, C. M., Argañaraz, E. R., & Planelles, V. (2007). HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system. Virology Journal. https://doi.org/10.1186/1743-422x-4-57

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.